Cns Pharmaceuticals, Inc.
CNSP
Revenue
0.00
0.000.00%
-Assets
11.87M
▼-2.64M▼-18.19%
3 Months ChangeLiabilities
1.96M
▲576.23k▲41.67%
3 Months ChangeFree Cash Flow
-3.08M
▲234.53k▲7.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001683168-26-001413
2026-02-17
Form 8-K
ID: 0001683168-26-001066
2025-12-17
Form 8-K
ID: 0001683168-25-009208
2025-11-21
Form 8-K
ID: 0001683168-25-008624
2025-11-14
Form 10-Q
ID: 0001683168-25-008466
2025-08-14
Form 10-Q
ID: 0001683168-25-006162
2025-07-22
Form 8-K
ID: 0001683168-25-005284
2025-07-15
Form 8-K
ID: 0001683168-25-005129
2025-05-15
Form 10-Q
ID: 0001683168-25-003733
2025-05-15
Form 8-K
ID: 0001683168-25-003575